在UFBP1上的Ufmylation通过调节肝脏内质网膜应激应变来缓解非酒精性脂肪性肝病
Ziming Mao1, Xiaowen Ma1, Yu Jing1
1Department of Endocrinology and Metabolism, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, 201999, China.
Cell death & disease
|September 2, 2023
概括
UFBP1的Ufmylation通过减少ER压力和改善脂质代谢来保护免受非酒精性脂肪性肝病 (NAFLD) 的影响. 这一发现为NAFLD治疗提供了潜在的治疗目标.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 是一种普遍存在的疾病,其特点是肝脏脂肪积累和内质网膜 (ER) 压力,有效治疗方法有限.
- Ufmylation是一种涉及Ubiquitin-fold修饰剂1 (UFM1) 的翻译后修饰,它调节了ER压力,可能在NAFLD病变发生过程中发挥作用.
研究的目的:
- 调查乌夫mylation在NAFLD发病过程中的作用,特别是其对UFM1结合蛋白1 (UFBP1) 的影响.
- 探索化影响NAFLD进展的潜在机制,并确定潜在的治疗点.
主要方法:
- 在NAFLD患者和模型肝脏中分析UFM1结合蛋白和ufmylation系统组件.
- 使用用自由脂肪酸 (FFA) 处理的肝细胞进行体外研究,以评估UFBP1的敲击和救援实验.
- 在高脂肪饮食 (HFD) 诱导的NAFLD小鼠模型中的体内研究,以评估ufmylation对UFBP1.1的影响.
主要成果:
- 在NAFLD肝脏中观察到化成分的表达增加,这表明对ER压力的适应性反应.
- 在实验室中除UFBP1会加剧脂质积累,而野生类型的UFBP1则挽救了这种效应.
- 在体内,UFBP1的化改善了HFD诱导的NAFLD小鼠的肥胖,肝硬化,失脂症,胰岛素耐药性和肝损伤.
- UFBP1的化减轻了ER的压力,这与改善的肝脂生和胰岛素抵抗有关.
结论:
- UFBP1的Ufmylation通过减轻ER压力和改善代谢功能障碍,对NAFLD起着保护作用.
- 针对UFBP1的化,为治疗NAFLD提供了一个有前途的治疗策略.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
137
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
137
The Unfolded Protein Response
4.7K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.7K
Regulation of the Unfolded Protein Response
2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K


